Nicotine protects rat brain mitochondria against experimental injuries
Identifieur interne : 000E95 ( PascalFrancis/Corpus ); précédent : 000E94; suivant : 000E96Nicotine protects rat brain mitochondria against experimental injuries
Auteurs : A. Cormier ; C. Morin ; R. Zini ; J.-P. Tillement ; G. LagrueSource :
- Neuropharmacology [ 0028-3908 ] ; 2003.
Abstract
Epidemiological studies have reported that cigarette smoking may protect from neurodegenerative diseases such as Parkinson's disease. These protective effects are thought to be mediated by nicotine. Recent data showed that nicotine significantly decreases respiratory control ratio (RCR) and superoxide anion generation of brain mitochondria. Thus, we investigated nicotine effects on rat brain in two experimental models: first, an in vitro anoxia/reoxygenation experiment and secondly, an in vivo rotenone-induced Parkinson-like syndrome. Anoxia/reoxygenation impaired mitochondrial respiration by 43.68% whereas in the presence of nicotine, it was less impaired, by 31.1% at 10-7 M. In rats chronically administered rotenone (3 mg/kg/day), we observed profound mitochondrial damage: the RCR decreased by 50.36% and the superoxide anion generation and the membrane anisotropy increased by 56.03 and 13.43%, respectively. All of these indications of mitochondrial damage were limited by chronic administration of nicotine. Nicotine developed mitochondrial effects in vivo and in vitro at very low concentration. All these results were in accordance with epidemiological studies, which report a protective effect of nicotine in neurodegenerative diseases. Thus, we propose that one effect of nicotine is to preserve mitochondrial functions of the rat central nervous system.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 03-0487051 INIST |
|---|---|
| ET : | Nicotine protects rat brain mitochondria against experimental injuries |
| AU : | CORMIER (A.); MORIN (C.); ZINI (R.); TILLEMENT (J.-P.); LAGRUE (G.) |
| AF : | Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail/94010 Creteil/France (1 aut., 2 aut., 3 aut., 4 aut.); Centre de Tabacologie, Hôpital Albert Chenevier/94010 Creteil/France (5 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Neuropharmacology; ISSN 0028-3908; Coden NEPHBW; Royaume-Uni; Da. 2003; Vol. 44; No. 5; Pp. 642-652; Bibl. 1 p.1/4 |
| LA : | Anglais |
| EA : | Epidemiological studies have reported that cigarette smoking may protect from neurodegenerative diseases such as Parkinson's disease. These protective effects are thought to be mediated by nicotine. Recent data showed that nicotine significantly decreases respiratory control ratio (RCR) and superoxide anion generation of brain mitochondria. Thus, we investigated nicotine effects on rat brain in two experimental models: first, an in vitro anoxia/reoxygenation experiment and secondly, an in vivo rotenone-induced Parkinson-like syndrome. Anoxia/reoxygenation impaired mitochondrial respiration by 43.68% whereas in the presence of nicotine, it was less impaired, by 31.1% at 10-7 M. In rats chronically administered rotenone (3 mg/kg/day), we observed profound mitochondrial damage: the RCR decreased by 50.36% and the superoxide anion generation and the membrane anisotropy increased by 56.03 and 13.43%, respectively. All of these indications of mitochondrial damage were limited by chronic administration of nicotine. Nicotine developed mitochondrial effects in vivo and in vitro at very low concentration. All these results were in accordance with epidemiological studies, which report a protective effect of nicotine in neurodegenerative diseases. Thus, we propose that one effect of nicotine is to preserve mitochondrial functions of the rat central nervous system. |
| CC : | 002B |
| LO : | INIST-10408.354000110911630100 |
| ID : | 03-0487051 |
Links to Exploration step
Pascal:03-0487051Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Nicotine protects rat brain mitochondria against experimental injuries</title><author><name sortKey="Cormier, A" sort="Cormier, A" uniqKey="Cormier A" first="A." last="Cormier">A. Cormier</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Morin, C" sort="Morin, C" uniqKey="Morin C" first="C." last="Morin">C. Morin</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zini, R" sort="Zini, R" uniqKey="Zini R" first="R." last="Zini">R. Zini</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tillement, J P" sort="Tillement, J P" uniqKey="Tillement J" first="J.-P." last="Tillement">J.-P. Tillement</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lagrue, G" sort="Lagrue, G" uniqKey="Lagrue G" first="G." last="Lagrue">G. Lagrue</name><affiliation><inist:fA14 i1="02"><s1>Centre de Tabacologie, Hôpital Albert Chenevier</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">03-0487051</idno><date when="2003">2003</date><idno type="stanalyst">PASCAL 03-0487051 INIST</idno><idno type="RBID">Pascal:03-0487051</idno><idno type="wicri:Area/PascalFrancis/Corpus">000E95</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Nicotine protects rat brain mitochondria against experimental injuries</title><author><name sortKey="Cormier, A" sort="Cormier, A" uniqKey="Cormier A" first="A." last="Cormier">A. Cormier</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Morin, C" sort="Morin, C" uniqKey="Morin C" first="C." last="Morin">C. Morin</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zini, R" sort="Zini, R" uniqKey="Zini R" first="R." last="Zini">R. Zini</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tillement, J P" sort="Tillement, J P" uniqKey="Tillement J" first="J.-P." last="Tillement">J.-P. Tillement</name><affiliation><inist:fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lagrue, G" sort="Lagrue, G" uniqKey="Lagrue G" first="G." last="Lagrue">G. Lagrue</name><affiliation><inist:fA14 i1="02"><s1>Centre de Tabacologie, Hôpital Albert Chenevier</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Neuropharmacology</title><title level="j" type="abbreviated">Neuropharmacology</title><idno type="ISSN">0028-3908</idno><imprint><date when="2003">2003</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Neuropharmacology</title><title level="j" type="abbreviated">Neuropharmacology</title><idno type="ISSN">0028-3908</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Epidemiological studies have reported that cigarette smoking may protect from neurodegenerative diseases such as Parkinson's disease. These protective effects are thought to be mediated by nicotine. Recent data showed that nicotine significantly decreases respiratory control ratio (RCR) and superoxide anion generation of brain mitochondria. Thus, we investigated nicotine effects on rat brain in two experimental models: first, an in vitro anoxia/reoxygenation experiment and secondly, an in vivo rotenone-induced Parkinson-like syndrome. Anoxia/reoxygenation impaired mitochondrial respiration by 43.68% whereas in the presence of nicotine, it was less impaired, by 31.1% at 10<sup>-7</sup> M. In rats chronically administered rotenone (3 mg/kg/day), we observed profound mitochondrial damage: the RCR decreased by 50.36% and the superoxide anion generation and the membrane anisotropy increased by 56.03 and 13.43%, respectively. All of these indications of mitochondrial damage were limited by chronic administration of nicotine. Nicotine developed mitochondrial effects in vivo and in vitro at very low concentration. All these results were in accordance with epidemiological studies, which report a protective effect of nicotine in neurodegenerative diseases. Thus, we propose that one effect of nicotine is to preserve mitochondrial functions of the rat central nervous system.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0028-3908</s0></fA01><fA02 i1="01"><s0>NEPHBW</s0></fA02><fA03 i2="1"><s0>Neuropharmacology</s0></fA03><fA05><s2>44</s2></fA05><fA06><s2>5</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Nicotine protects rat brain mitochondria against experimental injuries</s1></fA08><fA11 i1="01" i2="1"><s1>CORMIER (A.)</s1></fA11><fA11 i1="02" i2="1"><s1>MORIN (C.)</s1></fA11><fA11 i1="03" i2="1"><s1>ZINI (R.)</s1></fA11><fA11 i1="04" i2="1"><s1>TILLEMENT (J.-P.)</s1></fA11><fA11 i1="05" i2="1"><s1>LAGRUE (G.)</s1></fA11><fA14 i1="01"><s1>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ></fA14><fA14 i1="02"><s1>Centre de Tabacologie, Hôpital Albert Chenevier</s1><s2>94010 Creteil</s2><s3>FRA</s3><sZ>5 aut.</sZ></fA14><fA20><s1>642-652</s1></fA20><fA21><s1>2003</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>10408</s2><s5>354000110911630100</s5></fA43><fA44><s0>0000</s0><s1>© 2003 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>1 p.1/4</s0></fA45><fA47 i1="01" i2="1"><s0>03-0487051</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Neuropharmacology</s0></fA64><fA66 i1="01"><s0>GBR</s0></fA66><fC01 i1="01" l="ENG"><s0>Epidemiological studies have reported that cigarette smoking may protect from neurodegenerative diseases such as Parkinson's disease. These protective effects are thought to be mediated by nicotine. Recent data showed that nicotine significantly decreases respiratory control ratio (RCR) and superoxide anion generation of brain mitochondria. Thus, we investigated nicotine effects on rat brain in two experimental models: first, an in vitro anoxia/reoxygenation experiment and secondly, an in vivo rotenone-induced Parkinson-like syndrome. Anoxia/reoxygenation impaired mitochondrial respiration by 43.68% whereas in the presence of nicotine, it was less impaired, by 31.1% at 10<sup>-7</sup> M. In rats chronically administered rotenone (3 mg/kg/day), we observed profound mitochondrial damage: the RCR decreased by 50.36% and the superoxide anion generation and the membrane anisotropy increased by 56.03 and 13.43%, respectively. All of these indications of mitochondrial damage were limited by chronic administration of nicotine. Nicotine developed mitochondrial effects in vivo and in vitro at very low concentration. All these results were in accordance with epidemiological studies, which report a protective effect of nicotine in neurodegenerative diseases. Thus, we propose that one effect of nicotine is to preserve mitochondrial functions of the rat central nervous system.</s0></fC01><fC02 i1="01" i2="X"><s0>002B</s0></fC02><fN21><s1>328</s1></fN21><fN82><s1>DST</s1></fN82></pA></standard><server><NO>PASCAL 03-0487051 INIST</NO><ET>Nicotine protects rat brain mitochondria against experimental injuries</ET><AU>CORMIER (A.); MORIN (C.); ZINI (R.); TILLEMENT (J.-P.); LAGRUE (G.)</AU><AF>Laboratoire de Pharmacologie, Department de Pharmacologie, Faculté de Médecine de Paris XII, 8 rue de General Sarrail/94010 Creteil/France (1 aut., 2 aut., 3 aut., 4 aut.); Centre de Tabacologie, Hôpital Albert Chenevier/94010 Creteil/France (5 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Neuropharmacology; ISSN 0028-3908; Coden NEPHBW; Royaume-Uni; Da. 2003; Vol. 44; No. 5; Pp. 642-652; Bibl. 1 p.1/4</SO><LA>Anglais</LA><EA>Epidemiological studies have reported that cigarette smoking may protect from neurodegenerative diseases such as Parkinson's disease. These protective effects are thought to be mediated by nicotine. Recent data showed that nicotine significantly decreases respiratory control ratio (RCR) and superoxide anion generation of brain mitochondria. Thus, we investigated nicotine effects on rat brain in two experimental models: first, an in vitro anoxia/reoxygenation experiment and secondly, an in vivo rotenone-induced Parkinson-like syndrome. Anoxia/reoxygenation impaired mitochondrial respiration by 43.68% whereas in the presence of nicotine, it was less impaired, by 31.1% at 10<sup>-7</sup> M. In rats chronically administered rotenone (3 mg/kg/day), we observed profound mitochondrial damage: the RCR decreased by 50.36% and the superoxide anion generation and the membrane anisotropy increased by 56.03 and 13.43%, respectively. All of these indications of mitochondrial damage were limited by chronic administration of nicotine. Nicotine developed mitochondrial effects in vivo and in vitro at very low concentration. All these results were in accordance with epidemiological studies, which report a protective effect of nicotine in neurodegenerative diseases. Thus, we propose that one effect of nicotine is to preserve mitochondrial functions of the rat central nervous system.</EA><CC>002B</CC><LO>INIST-10408.354000110911630100</LO><ID>03-0487051</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E95 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000E95 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:03-0487051
|texte= Nicotine protects rat brain mitochondria against experimental injuries
}}
| This area was generated with Dilib version V0.6.29. |  |